Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4063142
Max Phase: Preclinical
Molecular Formula: C12H14F3N2O7P
Molecular Weight: 386.22
Molecule Type: Small molecule
Associated Items:
ID: ALA4063142
Max Phase: Preclinical
Molecular Formula: C12H14F3N2O7P
Molecular Weight: 386.22
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: N[C@@H](CCP(=O)(O)C(O)c1ccc(C(F)(F)F)c([N+](=O)[O-])c1)C(=O)O
Standard InChI: InChI=1S/C12H14F3N2O7P/c13-12(14,15)7-2-1-6(5-9(7)17(21)22)11(20)25(23,24)4-3-8(16)10(18)19/h1-2,5,8,11,20H,3-4,16H2,(H,18,19)(H,23,24)/t8-,11?/m0/s1
Standard InChI Key: RGHRXKZPSJWWED-YMNIQAILSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 386.22 | Molecular Weight (Monoisotopic): 386.0491 | AlogP: 1.68 | #Rotatable Bonds: 7 |
Polar Surface Area: 163.99 | Molecular Species: ZWITTERION | HBA: 6 | HBD: 4 |
#RO5 Violations: 0 | HBA (Lipinski): 9 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 0.95 | CX Basic pKa: 9.53 | CX LogP: -1.24 | CX LogD: -4.33 |
Aromatic Rings: 1 | Heavy Atoms: 25 | QED Weighted: 0.31 | Np Likeness Score: -0.02 |
1. Selvam C, Lemasson IA, Brabet I, Oueslati N, Karaman B, Cabaye A, Tora AS, Commare B, Courtiol T, Cesarini S, McCort-Tranchepain I, Rigault D, Mony L, Bessiron T, McLean H, Leroux FR, Colobert F, Daniel H, Goupil-Lamy A, Bertrand HO, Goudet C, Pin JP, Acher FC.. (2018) Increased Potency and Selectivity for Group III Metabotropic Glutamate Receptor Agonists Binding at Dual sites., 61 (5): [PMID:29397723] [10.1021/acs.jmedchem.7b01438] |
Source(1):